FDA Change In Bioequivalence Requirements Leads To Downgrade Of Accord’s Generic Tacrolimus

Downgrade
FDA downgrades the therapeutic equivalence rating of Accord Healthcare's tacrolimus generic drug product • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics